Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22051,194,0.92 [0.70-1.21],0.547085786044075
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23275,251,1.05 [0.82-1.34],0.6909017669134646
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22996,1773,1.05 [0.96-1.15],0.2743482260810247
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23281,558,1.20 [1.02-1.41],0.0317000224902664
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22515,4268,1.03 [0.97-1.10],0.3239964799926303
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22455,4349,1.11 [1.05-1.18],0.0004231243940542
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22986,1438,1.06 [0.95-1.17],0.3004606677701419
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23184,130,1.16 [0.82-1.63],0.4043298996791787
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20424,1312,1.04 [0.93-1.16],0.5167066533811939
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19707,1598,1.15 [1.04-1.27],0.0053986925756086
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19200,347,1.13 [0.91-1.40],0.2627494184582322
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15135,2774,1.10 [1.02-1.18],0.01847907928191
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19139,501,1.15 [0.96-1.37],0.1197059857520121
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23258,1710,1.07 [0.97-1.17],0.1915186949315399
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,23376,653,1.21 [1.04-1.41],0.0128241107283339
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22476,1253,1.07 [0.95-1.19],0.2578364238790995
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23303,1446,1.02 [0.92-1.13],0.7067461302552883
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21799,251,1.06 [0.83-1.35],0.6592731543503736
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23437,67,1.11 [0.69-1.79],0.6666847605312418
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23121,1264,1.02 [0.91-1.13],0.7644544090082365
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23135,81,0.81 [0.53-1.24],0.3368693336805095
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23372,143,0.91 [0.66-1.26],0.5724161016771916
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23349,120,0.87 [0.61-1.25],0.455787519954859
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21733,510,1.13 [0.95-1.34],0.1631811353270762
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21537,314,1.03 [0.83-1.28],0.8001476984631084
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21687,139,1.32 [0.95-1.83],0.1014735711385702
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23422,53,1.15 [0.68-1.95],0.5978640823400274
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23368,173,1.21 [0.90-1.64],0.2001126062479098
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,23250,55,1.44 [0.85-2.43],0.1727259914449163
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23274,79,1.28 [0.83-1.98],0.2628958462999784
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,23141,269,0.82 [0.65-1.03],0.0897134332985233
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23354,40,0.75 [0.40-1.38],0.3476873722186174
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23335,44,0.58 [0.34-1.00],0.0511695296393662
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11174,86,0.98 [0.65-1.49],0.9273827138896276
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22963,1697,0.96 [0.87-1.05],0.3521133246639197
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of meninges,23421,65,1.03 [0.63-1.69],0.9075203132937406
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23341,80,1.41 [0.91-2.18],0.1207012713268343
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23409,121,0.78 [0.55-1.10],0.1509433664605315
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of ovary,12194,81,0.80 [0.52-1.25],0.3259406559024055
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23397,447,0.95 [0.79-1.14],0.558166120159058
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,23402,391,1.00 [0.82-1.22],0.9672454333134994
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23287,88,0.60 [0.41-0.87],0.0079285224447169
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23393,257,0.98 [0.77-1.24],0.8535714422258708
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,23351,411,0.98 [0.80-1.18],0.8086707660331275
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23278,683,1.06 [0.91-1.23],0.4399477899825645
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23378,551,0.97 [0.82-1.14],0.6869723158563711
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Carcinoma in situ of breast,9165,48,0.86 [0.48-1.53],0.5998680320155645
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9209,66,1.01 [0.62-1.66],0.9602409271639928
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16719,72,0.79 [0.50-1.25],0.3196312688125994
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16748,101,1.25 [0.84-1.85],0.2675200420898147
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23380,126,1.01 [0.71-1.43],0.9720347449517104
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",23381,123,1.01 [0.70-1.44],0.9744269327590058
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,11921,171,1.16 [0.85-1.59],0.3367889628232094
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,14826,489,0.96 [0.81-1.14],0.6225911072980311
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Lymphoid leukaemia,16720,73,0.87 [0.55-1.39],0.5704649630321545
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16873,226,1.21 [0.93-1.58],0.1619724682650261
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16971,324,1.13 [0.91-1.40],0.2770704292480425
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9288,104,0.97 [0.66-1.43],0.8655456391388807
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16759,112,0.89 [0.62-1.29],0.5450520807890402
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16795,148,1.14 [0.83-1.56],0.4315356821081237
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16771,124,0.99 [0.70-1.40],0.9387875740814842
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9270,86,0.98 [0.63-1.51],0.916392037775166
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16775,128,0.66 [0.47-0.92],0.0147914577390907
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8450,987,1.06 [0.94-1.20],0.3507374600468462
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16785,138,0.80 [0.58-1.11],0.1847666428350093
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16739,92,0.69 [0.47-1.01],0.0555746563944448
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16789,142,0.98 [0.70-1.38],0.9231761332617022
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,23288,186,0.89 [0.67-1.19],0.4238323159740512
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,23408,79,1.24 [0.80-1.91],0.3414873882804825
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Melanoma in situ,16699,110,0.80 [0.55-1.17],0.2537259046868464
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16771,124,1.30 [0.91-1.85],0.1497617755847782
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16851,204,1.31 [0.99-1.73],0.0564518588650884
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16980,333,0.89 [0.72-1.09],0.2495629273126132
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16778,131,1.13 [0.80-1.59],0.5038251649326273
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,23262,165,0.83 [0.61-1.13],0.2328883265080782
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18158,1511,0.91 [0.82-1.01],0.0659892581087748
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18242,1595,0.93 [0.84-1.03],0.1419777008607458
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23125,402,0.87 [0.71-1.05],0.1424043298218913
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21084,164,2.90 [2.24-3.76],9.402098010086756e-16
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22794,71,1.40 [0.89-2.20],0.1461603474656304
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22657,3536,1.08 [1.01-1.15],0.0243199908624699
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21695,74,1.12 [0.71-1.76],0.6186057284981619
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22960,64,0.94 [0.58-1.52],0.7873720810195544
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22916,1996,1.11 [1.01-1.21],0.0238283387234427
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22914,1994,1.11 [1.01-1.21],0.0237809175144837
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21037,117,1.24 [0.86-1.78],0.2460128528515153
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23068,1447,1.15 [1.03-1.27],0.0091517990978856
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23008,112,0.78 [0.54-1.11],0.171313882124845
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22798,75,0.80 [0.52-1.24],0.3211761243107466
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22800,77,0.68 [0.45-1.05],0.0810820306660628
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23254,358,1.00 [0.82-1.23],0.999473620622492
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23304,41,1.93 [1.07-3.48],0.0289974760251139
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23189,293,1.00 [0.79-1.25],0.9667528608420454
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21759,138,0.79 [0.57-1.09],0.1553406234206303
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15671,422,1.20 [0.99-1.45],0.0584770278941295
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21911,104,0.63 [0.46-0.86],0.0039038091099118
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21923,116,0.44 [0.34-0.56],1.7227309921778459e-10
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15321,72,1.05 [0.65-1.68],0.8483642026885447
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21767,65,0.98 [0.60-1.60],0.9430149151006249
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20972,324,1.02 [0.82-1.27],0.8457411949928635
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22624,967,0.93 [0.82-1.05],0.222812867545099
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22148,491,1.11 [0.93-1.32],0.2683707900302003
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21879,222,0.97 [0.75-1.26],0.8244021810236866
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23146,1444,0.96 [0.86-1.06],0.4216633999353132
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19714,1400,0.94 [0.84-1.04],0.2099652227495798
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15342,93,1.33 [0.88-2.01],0.1700524670644612
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21110,99,0.81 [0.55-1.20],0.2968716925336473
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15620,371,1.19 [0.97-1.46],0.0988892274879417
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15306,57,0.73 [0.45-1.21],0.2257254484438048
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19907,4658,1.04 [0.98-1.10],0.2270278348147711
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15517,268,0.82 [0.65-1.04],0.1100677799121904
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15967,718,0.95 [0.82-1.10],0.513036689084289
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23377,376,1.41 [1.15-1.72],0.0007868255476341
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23164,163,1.93 [1.45-2.57],7.170247386302316e-06
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15404,155,0.92 [0.67-1.26],0.5898049192721004
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15331,82,1.42 [0.92-2.20],0.1176189190797207
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22790,1779,1.07 [0.97-1.18],0.1537009097260177
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15641,392,1.33 [1.10-1.61],0.0038124246423515
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15682,433,1.38 [1.15-1.67],0.0006019851575686
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16127,878,1.13 [0.99-1.29],0.0677443585304458
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15427,178,1.12 [0.83-1.51],0.4474319272816243
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23154,153,1.93 [1.43-2.60],1.432954867902388e-05
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,16153,904,1.08 [0.94-1.23],0.2712621485498542
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15912,663,0.83 [0.71-0.97],0.0162027722756773
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20728,80,1.72 [1.13-2.64],0.0123669848829677
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21765,6516,1.03 [0.98-1.09],0.1942527692725521
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21072,61,1.17 [0.70-1.94],0.556455030114984
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21062,51,1.54 [0.87-2.72],0.1349637387651724
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23248,1933,1.03 [0.94-1.12],0.5474200064077117
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23246,1931,1.02 [0.94-1.11],0.5681700564696981
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21078,67,1.17 [0.72-1.91],0.5150620373758514
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23076,1151,0.92 [0.82-1.04],0.1679402157467028
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17513,2264,1.11 [1.02-1.20],0.0162734113961681
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23421,319,0.72 [0.58-0.88],0.0014796158965281
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21791,134,1.18 [0.84-1.64],0.3421198782124414
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22044,119,0.88 [0.61-1.25],0.4715685329598144
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22091,166,0.90 [0.67-1.22],0.4995567108492568
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15448,199,1.11 [0.83-1.48],0.5009285253787341
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20596,185,0.39 [0.30-0.50],9.807712198452606e-13
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2509,102,1.03 [0.75-1.43],0.8474154485812789
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2678,313,0.97 [0.81-1.16],0.7316700980752888
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20499,88,0.53 [0.35-0.80],0.0022924186599062
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2481,77,1.65 [1.15-2.38],0.0070138278668266
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22575,2164,0.67 [0.62-0.73],3.123993026957495e-20
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22295,638,0.90 [0.77-1.05],0.1834114004718326
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21104,456,1.00 [0.83-1.20],0.9960386709494796
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16383,1134,1.06 [0.94-1.19],0.3653170976480993
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23299,309,0.93 [0.75-1.16],0.518577625412779
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21912,272,1.55 [1.23-1.94],0.0001603069607782
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,20238,1595,1.04 [0.95-1.15],0.3987277453230233
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22017,377,1.49 [1.23-1.82],5.677657222397093e-05
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21730,90,0.86 [0.57-1.28],0.4494929896812638
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21936,296,1.36 [1.09-1.70],0.007281495268706
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11850,2883,1.06 [0.99-1.14],0.103067196452
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,AV-block,17791,686,1.07 [0.92-1.25],0.3662254578886682
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23354,588,1.09 [0.93-1.28],0.2879670809638021
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,9238,271,1.54 [1.21-1.96],0.0004911627377977
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17309,204,1.26 [0.96-1.67],0.0984347672024489
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17216,111,1.73 [1.20-2.49],0.0031217532694228
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23432,83,1.10 [0.72-1.68],0.6581010839884002
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,18686,1581,1.08 [0.98-1.19],0.1210295670006444
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21407,2789,1.08 [1.01-1.17],0.0321380571906143
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18792,9013,0.95 [0.91-0.99],0.0258956962097737
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21839,340,0.99 [0.80-1.22],0.9100102225353928
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Endocarditis,17208,103,0.84 [0.57-1.24],0.3812044903267106
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23139,1691,1.13 [1.03-1.24],0.0099813832366189
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,20048,8023,0.96 [0.92-1.01],0.0879519276424433
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20067,8042,0.97 [0.92-1.01],0.1436534306162296
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23262,100,0.67 [0.46-0.97],0.0335467643105043
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12292,267,1.10 [0.87-1.41],0.4237216411687414
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12238,213,3.40 [2.84-4.08],3.1916508143073243e-40
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,23251,1666,1.11 [1.01-1.23],0.0258687925983257
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22123,150,0.85 [0.62-1.18],0.3323642033948336
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21586,2943,1.05 [0.97-1.12],0.2289071452016046
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22913,811,0.89 [0.78-1.02],0.1021926542882941
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17639,534,1.27 [1.07-1.50],0.0068826876911876
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22733,1077,0.90 [0.80-1.01],0.0723861872900795
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19571,928,0.98 [0.86-1.12],0.7792626145659698
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23306,190,1.28 [0.97-1.70],0.0796119672678289
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23391,413,0.88 [0.72-1.06],0.1705992432377656
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21568,69,0.92 [0.58-1.45],0.7163456003669316
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,21747,107,1.27 [0.87-1.85],0.2208712945538752
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17711,606,1.11 [0.94-1.30],0.2205041903439884
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21779,139,1.02 [0.74-1.42],0.8819970092913612
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21976,336,0.88 [0.71-1.08],0.2136193088533896
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17333,228,1.18 [0.91-1.54],0.2116041831690266
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,21620,121,0.93 [0.66-1.32],0.6860296702028966
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21546,47,0.78 [0.45-1.37],0.3950084845303296
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21346,92,1.17 [0.78-1.76],0.4341830666456872
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21682,183,1.03 [0.78-1.37],0.8254543902306875
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18587,1482,1.18 [1.06-1.30],0.0016213751287124
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21648,63,0.53 [0.34-0.82],0.0046209430769749
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22385,745,1.07 [0.93-1.24],0.340433383345006
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22657,538,1.20 [1.02-1.41],0.0324915344236776
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22247,993,0.85 [0.75-0.97],0.0117552333681311
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9385,418,1.26 [1.04-1.53],0.0188958871756014
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22208,605,1.03 [0.88-1.21],0.6947953202775975
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21930,431,0.94 [0.78-1.14],0.5468893413369549
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22725,606,1.18 [1.00-1.38],0.0432594530013905
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23336,984,1.04 [0.92-1.18],0.5017593928040143
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17630,525,1.15 [0.97-1.37],0.1056071635609937
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22650,531,1.19 [1.01-1.40],0.0391567378009796
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21524,270,0.95 [0.75-1.20],0.6796467368769161
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22897,924,0.89 [0.79-1.02],0.0851958576308308
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22882,965,0.92 [0.81-1.04],0.1943177159455481
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22091,64,1.42 [0.87-2.33],0.1629043508803684
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21747,107,2.06 [1.44-2.94],6.865573522277681e-05
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22431,329,1.14 [0.92-1.41],0.2461269337787749
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21996,340,0.81 [0.66-0.99],0.0422599153421471
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,22024,525,1.01 [0.85-1.20],0.9192268464361372
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21660,124,0.87 [0.61-1.24],0.4384855369087274
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23153,960,1.07 [0.94-1.21],0.3032070608913175
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23352,338,0.56 [0.47-0.67],4.0860422397309484e-10
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20017,1402,0.91 [0.81-1.01],0.0659234306165006
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,22893,4278,0.93 [0.87-0.99],0.0146672751920686
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23323,398,0.60 [0.50-0.71],5.230745604364839e-09
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20087,1472,0.94 [0.85-1.04],0.2337920953994996
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18701,86,0.56 [0.39-0.82],0.0029363392204958
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,22918,1191,0.90 [0.81-1.01],0.0643202774489527
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20083,1468,0.85 [0.77-0.94],0.0010658046409727
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Vascular dementia,22518,233,1.13 [0.88-1.46],0.339482174645924
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,23433,602,1.11 [0.95-1.31],0.1906658331484394
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",14343,112,0.98 [0.67-1.44],0.9318327784625432
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Bell's palsy,21560,86,0.82 [0.54-1.24],0.34902169708533
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21977,503,0.92 [0.78-1.10],0.3698608171809746
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,22976,252,1.05 [0.82-1.35],0.6971032007915456
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23359,415,0.92 [0.76-1.11],0.4030349066241159
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22565,77,1.17 [0.75-1.83],0.4830532056667946
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23415,70,0.73 [0.47-1.14],0.1677735336704409
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22812,88,1.08 [0.71-1.64],0.7312199074150563
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,21901,310,1.09 [0.87-1.37],0.4480752203211723
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22962,1371,1.10 [0.99-1.22],0.0764661655371702
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23381,939,0.88 [0.77-1.00],0.0442893698492706
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22761,3492,0.96 [0.90-1.03],0.2836901294658044
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23045,54,0.74 [0.44-1.25],0.2663612457347228
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,23284,340,0.95 [0.77-1.17],0.6354242925837732
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,22798,74,0.99 [0.62-1.57],0.9574059781373344
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23420,72,0.91 [0.57-1.46],0.707921819806135
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21542,68,1.05 [0.64-1.71],0.8577048949096537
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21548,74,0.81 [0.52-1.26],0.3520552236866336
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Memory loss,22263,144,0.70 [0.51-0.97],0.0311100316515261
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,21873,282,0.96 [0.76-1.23],0.7703359127110334
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23385,259,0.92 [0.72-1.18],0.502064882226342
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,14433,178,1.01 [0.75-1.37],0.9385249822477316
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23302,61,0.84 [0.51-1.39],0.5070892761559791
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22716,1242,1.02 [0.91-1.14],0.7767507689653322
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,21925,4420,1.01 [0.95-1.07],0.793336694107
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22818,330,0.82 [0.67-1.02],0.0711142539232434
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21903,429,1.07 [0.89-1.30],0.4679555191436364
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23353,357,0.85 [0.69-1.04],0.1081366584153009
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17523,994,0.99 [0.87-1.13],0.90616545708393
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22814,90,1.06 [0.70-1.59],0.7965846739746106
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22888,164,1.15 [0.85-1.56],0.3492122928770257
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22680,238,0.77 [0.60-0.99],0.0381869157481056
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21571,97,0.88 [0.59-1.30],0.519900949670054
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,21644,53,0.80 [0.47-1.36],0.4041643003081985
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,23317,593,1.01 [0.86-1.18],0.9455330752479624
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,22115,524,1.09 [0.92-1.28],0.308157996489177
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,23402,697,0.87 [0.75-1.01],0.0741195722204225
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22769,45,1.07 [0.59-1.95],0.8173631092050662
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23434,108,0.77 [0.53-1.12],0.1749459851845595
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,23197,444,1.04 [0.88-1.24],0.6336088059740526
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23057,61,1.20 [0.72-1.99],0.4818733112888531
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23422,207,0.99 [0.75-1.30],0.9274931804800072
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21543,69,0.95 [0.59-1.53],0.8419884597227651
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23433,608,1.12 [0.95-1.31],0.1680126370774835
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22455,227,1.13 [0.88-1.47],0.3403505157754523
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22780,157,1.03 [0.75-1.41],0.8495739460347973
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22968,568,1.03 [0.87-1.22],0.733191345204367
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23173,271,0.58 [0.47-0.72],5.732535624215599e-07
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22182,70,0.79 [0.49-1.25],0.3130290677313869
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22150,38,0.86 [0.46-1.63],0.651683059400453
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23310,74,0.99 [0.63-1.55],0.954794635770243
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23109,227,1.11 [0.85-1.44],0.4407943924575627
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2485,78,1.24 [0.86-1.80],0.2483366337811131
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3070,117,0.85 [0.63-1.13],0.2560926275051006
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22730,107,1.01 [0.69-1.48],0.9540081248697044
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23128,1447,0.95 [0.86-1.05],0.3188826625963825
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23011,899,0.93 [0.82-1.06],0.3028307429414449
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22420,308,0.96 [0.77-1.20],0.7156741552038717
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23357,957,1.07 [0.94-1.21],0.3298533367342113
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23427,82,1.17 [0.76-1.80],0.4866155198979387
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23284,884,1.03 [0.90-1.18],0.6517960818484345
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23390,508,1.09 [0.92-1.30],0.324387281796906
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23311,230,0.93 [0.72-1.20],0.5715793455677806
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22214,102,0.76 [0.52-1.11],0.153726538544225
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22218,106,0.86 [0.59-1.25],0.4254488505089489
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22189,77,0.86 [0.55-1.34],0.5052194473546732
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23296,1029,0.93 [0.82-1.05],0.2408510785063486
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22536,269,0.92 [0.72-1.17],0.4828144066804408
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22473,73,0.84 [0.53-1.33],0.4554700407380864
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23009,127,1.07 [0.75-1.51],0.7195349571736127
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23277,395,1.16 [0.95-1.41],0.155312027215193
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22622,222,0.99 [0.76-1.29],0.9233131628809308
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23226,145,1.00 [0.72-1.39],0.99754584099766
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22956,689,0.95 [0.82-1.10],0.4992994523302509
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22785,162,1.00 [0.73-1.36],0.9856038501703448
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20953,3285,0.97 [0.91-1.04],0.4196780119060143
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23231,349,1.15 [0.93-1.42],0.2010846651573149
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23420,193,0.95 [0.72-1.26],0.7106106871947576
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22664,552,0.91 [0.77-1.08],0.2873302122188963
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22975,93,1.08 [0.72-1.63],0.6940997027558798
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23418,73,1.05 [0.67-1.66],0.8212680309849104
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22242,130,1.02 [0.72-1.44],0.906183804447502
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22289,177,1.11 [0.82-1.49],0.496235772092414
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21848,167,0.75 [0.56-1.02],0.065050658712236
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22464,64,1.65 [1.02-2.67],0.0428419222607228
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21756,75,0.84 [0.53-1.33],0.4456014164318493
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22384,117,0.70 [0.49-1.00],0.0520424218419553
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22563,296,1.08 [0.86-1.36],0.5013155312292793
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22276,164,0.86 [0.64-1.17],0.3387409620368752
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21778,97,0.91 [0.61-1.37],0.6526495421842264
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21815,134,0.97 [0.69-1.37],0.8786365311088378
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20436,2768,1.01 [0.94-1.09],0.8159919950888384
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22203,91,0.92 [0.61-1.39],0.6959157297134937
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23134,511,0.97 [0.82-1.16],0.7485317704360248
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22702,79,0.96 [0.62-1.47],0.8370200647456978
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22834,211,0.90 [0.68-1.17],0.4220065788707214
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23210,115,1.26 [0.87-1.83],0.2148710323556675
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23387,141,1.02 [0.74-1.42],0.8938775680304857
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23294,119,0.89 [0.62-1.27],0.5110655949623755
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23161,66,0.84 [0.52-1.37],0.4807959760661904
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23164,69,0.83 [0.52-1.33],0.4361433072632978
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23326,1264,0.93 [0.83-1.04],0.2009720476291385
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23020,958,0.91 [0.80-1.03],0.1379955214974087
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22217,155,0.99 [0.72-1.36],0.9622649515205453
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22153,91,0.69 [0.46-1.02],0.0649025290882902
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23239,68,1.52 [0.95-2.41],0.0780418679213466
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23361,190,1.17 [0.88-1.55],0.2863534954645878
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23235,64,1.48 [0.92-2.39],0.1042183675274264
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,All influenza,20710,159,1.26 [0.92-1.72],0.1527822341521785
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20707,156,1.29 [0.94-1.77],0.1187969084577828
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14442,105,1.04 [0.70-1.54],0.8620878860122181
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23325,240,0.93 [0.72-1.20],0.5890836690579322
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15672,1732,0.95 [0.86-1.05],0.2935001047136671
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16047,1710,0.95 [0.86-1.05],0.3295807758223796
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22905,181,0.80 [0.61-1.06],0.1241397791259024
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20656,105,0.73 [0.51-1.05],0.0891949010199123
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,19645,526,1.14 [0.96-1.36],0.1328557446628188
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19194,75,1.17 [0.74-1.85],0.4972070193606562
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22285,3166,1.01 [0.94-1.08],0.7311714875327672
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22199,73,1.07 [0.67-1.72],0.7626637042177253
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22262,136,0.71 [0.51-0.98],0.0397136044881636
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23137,1653,1.02 [0.93-1.12],0.6315216569794208
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22206,80,1.18 [0.76-1.83],0.4647173166190858
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21250,6183,1.00 [0.95-1.05],0.9992441556583794
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22467,341,0.91 [0.74-1.12],0.3764004855032727
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,21594,110,1.10 [0.76-1.59],0.6103193915663825
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Emphysema,19561,442,1.05 [0.87-1.26],0.6077228459141716
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22110,459,1.04 [0.86-1.24],0.7028212197513504
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23173,2622,1.07 [0.99-1.15],0.097986700120298
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22155,504,1.06 [0.89-1.26],0.507997027372961
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Later onset COPD,22903,1543,1.02 [0.92-1.12],0.716819411467557
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23418,505,1.15 [0.97-1.36],0.1159175042009606
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,22224,98,0.78 [0.53-1.16],0.2201978964223908
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23145,1324,1.06 [0.95-1.18],0.2904648330961649
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23136,2722,1.01 [0.94-1.09],0.7540237434828281
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22885,759,0.89 [0.78-1.03],0.1252137842356712
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,20483,69,0.81 [0.51-1.30],0.3871080210669005
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23311,603,1.09 [0.93-1.27],0.2873902116955651
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23302,1735,1.04 [0.95-1.15],0.3581858549952924
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,21803,1389,1.05 [0.95-1.17],0.3625626740112483
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pleural plaque,20668,254,0.91 [0.71-1.16],0.4447210811969496
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22880,2329,1.07 [0.99-1.16],0.0885478229708513
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23308,395,1.09 [0.90-1.33],0.3735751701708514
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pneumothorax,20585,171,0.79 [0.59-1.05],0.1084818547755523
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pollen allergy,23422,204,0.91 [0.69-1.20],0.5006551446566943
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,22803,95,1.39 [0.94-2.04],0.0988083571816643
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14407,70,1.15 [0.71-1.86],0.5811883001014678
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23121,1300,1.05 [0.94-1.17],0.3619785188011236
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22368,242,0.93 [0.72-1.20],0.5566489324622421
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,20858,307,1.00 [0.80-1.24],0.9686945311638512
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22915,245,0.95 [0.75-1.22],0.7076540168099162
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7467,122,0.94 [0.65-1.37],0.7605185861972882
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14844,61,0.72 [0.44-1.17],0.1830748404285012
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,23318,129,0.96 [0.68-1.36],0.8326405206053131
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute gastritis,16281,107,1.34 [0.92-1.97],0.1292128103815758
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21363,203,1.03 [0.78-1.35],0.8529018610922255
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,22934,110,1.14 [0.79-1.65],0.4833648854396285
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22442,66,0.57 [0.37-0.88],0.0111263616152641
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,16691,517,1.05 [0.88-1.25],0.5995620611761334
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21308,148,0.90 [0.65-1.23],0.492046294436506
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23011,148,0.89 [0.65-1.23],0.4872477661692737
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,21384,224,0.98 [0.76-1.27],0.8861961402760469
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,22224,1064,0.96 [0.85-1.08],0.4668745718219536
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,16526,352,0.90 [0.73-1.11],0.3401880706751546
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21215,55,0.54 [0.33-0.87],0.01167139553872
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23294,132,0.48 [0.36-0.64],5.925350674708476e-07
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,21673,128,0.98 [0.69-1.41],0.9273210068423974
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,21675,104,1.15 [0.77-1.71],0.4928451550617722
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23315,161,1.11 [0.82-1.51],0.4965286407638805
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,23145,2165,0.90 [0.83-0.98],0.0132993318220867
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,21660,89,1.33 [0.88-2.01],0.1828870499595246
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23081,68,1.42 [0.89-2.27],0.1439300220227932
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21652,81,1.47 [0.96-2.27],0.0790048283178297
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,22806,189,0.97 [0.73-1.29],0.8470381879115647
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20234,2592,1.02 [0.94-1.10],0.6948165829235644
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,23347,158,0.91 [0.66-1.24],0.5467277884338462
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,23311,935,0.92 [0.81-1.05],0.2218412484125309
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20831,4657,1.01 [0.95-1.07],0.7904091123273485
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23094,477,0.94 [0.79-1.13],0.5310818397837318
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23341,517,0.95 [0.80-1.13],0.5948068312413385
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22708,91,0.76 [0.51-1.13],0.1711235039142128
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22583,60,0.79 [0.48-1.30],0.3477603792610806
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23091,1546,0.98 [0.89-1.09],0.7566220212242576
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,22601,96,1.18 [0.79-1.77],0.4172940379662669
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22703,1543,0.95 [0.86-1.05],0.361266582598359
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18616,3833,0.94 [0.88-1.00],0.0517070941843895
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,16426,252,1.14 [0.89-1.46],0.282188475175487
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23338,205,1.09 [0.83-1.43],0.5346450981918311
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23395,28,1.06 [0.50-2.26],0.8814122717789696
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22530,154,0.60 [0.45-0.81],0.0006321010016719
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14893,110,1.08 [0.74-1.58],0.6778405835095198
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16746,572,1.03 [0.87-1.22],0.720718019750175
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,16606,432,1.14 [0.94-1.38],0.1709381735538868
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18882,2708,0.98 [0.91-1.06],0.6067480323495944
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16836,662,1.11 [0.95-1.29],0.193230829916524
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16908,8321,0.99 [0.94-1.03],0.5892377309080916
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,22830,1285,1.01 [0.91-1.13],0.8206438835785541
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22662,45,0.82 [0.46-1.45],0.4986052734422788
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15783,1194,0.94 [0.83-1.05],0.2706716507660226
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22446,70,0.76 [0.48-1.19],0.2266078213799785
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,21342,3700,1.02 [0.96-1.09],0.5590140123893583
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,23399,26,1.04 [0.47-2.29],0.9221111830805464
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,14862,79,1.25 [0.80-1.96],0.3319324998574574
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,18763,1121,1.02 [0.90-1.14],0.7943123255444775
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17768,126,0.87 [0.61-1.24],0.4420552227135734
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14900,117,0.75 [0.52-1.07],0.1127685769608918
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21692,147,0.99 [0.71-1.38],0.93916454862386
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15298,515,0.98 [0.82-1.18],0.8598425988919515
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23401,344,0.80 [0.65-0.98],0.0305436804682722
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22361,790,0.93 [0.81-1.07],0.3419324732274925
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22669,1098,0.98 [0.87-1.11],0.7782539606381453
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16398,224,0.82 [0.63-1.07],0.1391518687318336
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,16880,706,0.87 [0.75-1.01],0.0643481212642748
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23377,131,0.92 [0.66-1.30],0.6514325353857022
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17728,86,1.22 [0.80-1.86],0.3482965218614924
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16173,1390,0.90 [0.81-1.00],0.0575858710716365
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21526,366,0.89 [0.72-1.09],0.2482064477344115
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21308,148,0.98 [0.71-1.35],0.8972656356531232
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16747,1964,1.01 [0.92-1.11],0.8120939759582084
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21082,6299,0.96 [0.91-1.01],0.0803686555247816
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22556,207,0.92 [0.70-1.21],0.5438724499642189
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,23151,775,0.92 [0.80-1.06],0.2437798821648567
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16957,783,0.99 [0.86-1.14],0.9060032035071706
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21378,218,0.78 [0.60-1.01],0.0546593904511592
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23264,440,0.91 [0.76-1.10],0.3352056436191368
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17282,1108,0.96 [0.85-1.08],0.5038420640071903
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22847,1302,1.02 [0.91-1.13],0.7734264672917226
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22798,181,0.94 [0.70-1.25],0.6491653232881192
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16995,2212,0.91 [0.83-0.98],0.020138498282036
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18372,2198,1.04 [0.96-1.13],0.3574570753741155
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22493,117,0.93 [0.65-1.32],0.6735299624413438
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22539,968,0.98 [0.87-1.12],0.7992798066056421
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15238,455,1.06 [0.88-1.28],0.5311967065983243
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23391,32,1.22 [0.60-2.47],0.5837669471890028
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15411,628,1.13 [0.97-1.33],0.1234356657917407
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21702,157,0.68 [0.50-0.92],0.0120155482728092
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23422,54,0.75 [0.45-1.27],0.2846641048731215
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22611,105,1.04 [0.71-1.54],0.8322420460299795
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Toxic colitis,21652,81,1.47 [0.95-2.27],0.0842682678098696
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16520,346,0.88 [0.71-1.08],0.2186396039443709
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21741,170,0.62 [0.46-0.83],0.0012739060825024
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21706,135,0.58 [0.42-0.80],0.0008943494729038
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,17899,257,1.27 [1.00-1.61],0.0528833966669103
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,15032,249,1.05 [0.82-1.36],0.6796220675625697
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,17935,293,0.93 [0.74-1.16],0.5124428628194442
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Volvulus,14877,94,1.45 [0.96-2.19],0.0785596573323844
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23325,431,1.15 [0.95-1.39],0.1642336800431201
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23067,67,0.96 [0.60-1.55],0.8751394255100662
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20836,167,1.15 [0.84-1.57],0.3722782953047047
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22784,839,1.07 [0.94-1.22],0.2995147559455612
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22092,147,0.98 [0.71-1.35],0.906018329011662
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21309,640,1.04 [0.89-1.21],0.6521349005613992
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23085,322,1.28 [1.03-1.59],0.0273493789837916
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23332,569,1.17 [1.00-1.38],0.0545355024007264
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22812,49,0.75 [0.43-1.29],0.3013040205595761
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21807,3792,1.06 [0.99-1.13],0.0939081355560882
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22992,450,0.93 [0.77-1.12],0.4395027265068923
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22856,314,0.90 [0.72-1.12],0.3331334988728469
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23040,1095,1.05 [0.94-1.18],0.373754016539083
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23414,62,1.45 [0.88-2.39],0.147415079642193
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20726,57,0.86 [0.51-1.46],0.5863236981073029
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22606,64,0.87 [0.54-1.41],0.5755021254478032
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23071,308,1.33 [1.06-1.66],0.0121862522258184
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21283,614,1.07 [0.91-1.25],0.4360625252798882
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20761,92,1.20 [0.79-1.82],0.3841971130523276
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23345,96,1.01 [0.69-1.50],0.9409087773229308
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22190,245,1.01 [0.79-1.29],0.9267958674155968
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23226,226,0.85 [0.66-1.09],0.2010762342555199
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22860,97,1.22 [0.83-1.80],0.3192094308422862
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20749,80,0.98 [0.63-1.54],0.9396095702252164
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22813,2144,1.02 [0.94-1.11],0.6723501460418697
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21329,660,1.04 [0.89-1.21],0.6309158001215365
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20765,96,1.13 [0.75-1.70],0.5605869211455312
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23341,341,1.00 [0.81-1.24],0.9955585726802096
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22840,77,0.87 [0.56-1.35],0.5277925272154136
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23278,278,0.90 [0.71-1.13],0.3613868589839212
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23358,464,1.13 [0.94-1.35],0.2112149483588521
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20794,125,1.22 [0.85-1.75],0.2770641850765563
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21013,344,0.92 [0.74-1.14],0.4386568041466999
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23346,452,1.13 [0.93-1.36],0.2176366113792697
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21011,342,0.78 [0.64-0.95],0.0152822112920357
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23406,157,1.08 [0.79-1.47],0.6222455773421958
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19530,83,0.69 [0.45-1.03],0.0719535971159272
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20648,6530,1.00 [0.95-1.05],0.9155836198620112
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19220,5102,0.98 [0.92-1.03],0.4135846221027736
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19499,52,0.68 [0.40-1.16],0.1571115742756697
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19435,148,1.22 [0.88-1.69],0.2306686439973869
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19484,197,0.98 [0.74-1.30],0.8758874633921832
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23166,66,0.89 [0.55-1.44],0.6392658102629212
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19439,152,0.81 [0.59-1.12],0.2104158270045494
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15623,1505,0.98 [0.88-1.08],0.6498963925016812
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23218,250,1.07 [0.83-1.37],0.6062832409312922
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19878,591,0.99 [0.84-1.17],0.9527049293810008
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18959,8148,1.01 [0.97-1.06],0.6729108005114697
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20853,124,0.83 [0.58-1.18],0.3046730594387808
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19631,184,0.77 [0.58-1.02],0.0653481593581878
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19963,516,0.85 [0.71-1.01],0.07045644872913
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22480,3193,1.01 [0.94-1.09],0.7419550837593265
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19760,313,0.69 [0.55-0.85],0.0006343031411661
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19599,152,1.18 [0.85-1.63],0.3343068513365345
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19567,120,0.83 [0.57-1.19],0.3070627873302402
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22671,103,1.28 [0.86-1.90],0.2183659491314126
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16157,2039,0.93 [0.85-1.02],0.1053186561608008
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14928,810,1.19 [1.04-1.36],0.0108934825139743
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23335,803,1.23 [1.08-1.41],0.0020850831132962
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14197,79,0.79 [0.50-1.25],0.3069058439223451
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14425,307,1.06 [0.84-1.35],0.6234912441515374
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19715,268,0.91 [0.72-1.16],0.4663767242315165
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14602,484,0.78 [0.65-0.93],0.0060999252490839
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19369,82,0.85 [0.55-1.32],0.4824112346120551
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19980,693,0.92 [0.79-1.07],0.2735987967668754
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19604,317,0.95 [0.76-1.18],0.6335540725467442
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14572,454,0.77 [0.64-0.93],0.0058015600454646
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19519,72,0.87 [0.55-1.38],0.5490552998076307
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19507,60,0.91 [0.55-1.51],0.7114976464038167
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20816,87,0.63 [0.43-0.93],0.0207300520275678
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22996,2267,0.97 [0.89-1.05],0.4064960217986991
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22317,1588,0.99 [0.90-1.10],0.8689456524683674
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23260,545,1.07 [0.90-1.26],0.4575448985166344
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17299,3181,0.99 [0.93-1.07],0.8529718949840042
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14161,43,0.49 [0.27-0.89],0.0181554452865176
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19555,108,0.81 [0.56-1.18],0.2720875269231152
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14190,72,1.01 [0.64-1.60],0.97032946832884
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14255,137,0.96 [0.68-1.37],0.8392237597872062
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20977,248,1.07 [0.83-1.37],0.6080701264573916
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21248,519,1.12 [0.93-1.33],0.2292793976958136
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23410,115,1.12 [0.78-1.62],0.5399377839742945
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21308,2021,0.99 [0.91-1.08],0.8644541704218844
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19526,79,1.04 [0.66-1.63],0.8768192322453054
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14276,158,0.91 [0.65-1.26],0.5524606677893081
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20088,801,1.00 [0.87-1.15],0.9683418216969172
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16330,2212,0.88 [0.81-0.96],0.0037428962839355
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22698,130,1.38 [0.97-1.95],0.0705773277244611
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23422,64,0.95 [0.59-1.55],0.8439458506350024
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19526,79,1.01 [0.65-1.56],0.974456236939681
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20821,1374,0.95 [0.86-1.06],0.392426400794141
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19555,108,0.90 [0.62-1.32],0.5930388120835068
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16221,2103,0.97 [0.89-1.06],0.4751535098394016
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20848,119,1.12 [0.78-1.61],0.544455014982608
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19485,38,0.66 [0.35-1.25],0.2017737454035852
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19487,200,0.97 [0.73-1.28],0.8150774372788485
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20142,695,1.10 [0.94-1.27],0.2291057455056444
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23065,497,1.22 [1.02-1.46],0.030594678785269
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19959,672,0.96 [0.82-1.12],0.6089642017048051
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23275,539,1.08 [0.91-1.27],0.3942974739476068
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23407,69,1.60 [1.00-2.56],0.0496161237674179
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19615,168,0.69 [0.51-0.94],0.0170908327872294
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18214,902,0.92 [0.81-1.05],0.2381968777749286
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20102,655,0.84 [0.72-0.97],0.0195609305041944
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19728,281,0.68 [0.54-0.85],0.0006428035670396
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14189,71,0.85 [0.53-1.37],0.5169963058365813
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17288,3170,1.01 [0.94-1.08],0.8286115548770936
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14969,851,0.93 [0.81-1.07],0.3186242227237718
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22947,379,1.15 [0.94-1.41],0.1807272693875037
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23377,82,1.11 [0.71-1.72],0.6499800466050927
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20733,71,0.87 [0.55-1.35],0.5285628079877553
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14183,65,0.96 [0.59-1.59],0.8875420675079946
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19397,110,0.99 [0.68-1.45],0.972032915834246
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14671,553,1.08 [0.91-1.28],0.3837003244722099
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19788,341,0.84 [0.68-1.04],0.1055772942334487
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19581,294,1.10 [0.87-1.38],0.4385594722321683
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19556,269,1.10 [0.86-1.41],0.4517083555237993
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16447,68,0.72 [0.44-1.16],0.1748853664820536
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23412,74,1.65 [1.05-2.60],0.0286067152236152
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20008,561,0.89 [0.76-1.06],0.1867654062862329
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22663,95,1.51 [1.00-2.28],0.0504322620088517
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22129,2682,0.93 [0.86-1.00],0.0644552827637574
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19597,150,0.89 [0.64-1.23],0.4709646492022953
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20013,726,0.99 [0.86-1.15],0.9267537428868848
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22046,280,0.93 [0.73-1.17],0.5311017422252851
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19546,259,0.91 [0.71-1.17],0.4723744203123527
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21321,2034,1.04 [0.95-1.14],0.3693443490488337
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20612,1325,1.08 [0.97-1.21],0.158891717025056
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19511,64,0.83 [0.51-1.37],0.471005399977083
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22688,120,1.28 [0.89-1.84],0.1792528394528445
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19611,164,1.28 [0.94-1.75],0.1144704779682201
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19538,91,0.88 [0.58-1.34],0.5504275068232871
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14196,78,0.63 [0.41-0.99],0.042938561613591
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21893,2286,1.36 [1.25-1.48],2.14905578757232e-13
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9380,26,0.60 [0.29-1.22],0.1546915685755435
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11901,34,1.40 [0.70-2.80],0.3484758601116235
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23100,317,0.95 [0.77-1.18],0.660917145248695
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22889,106,1.09 [0.75-1.59],0.6488483635595207
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21978,2371,2.16 [2.00-2.33],6.257590282014316e-86
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23194,133,2.76 [2.15-3.55],1.643426981055969e-15
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23118,412,1.51 [1.25-1.82],1.7952864979284833e-05
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,19523,303,0.90 [0.71-1.12],0.3384207785126464
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,19706,99,5.53 [4.37-7.01],1.5888471093140838e-45
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10328,2173,1.07 [0.98-1.16],0.1296792985519027
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12002,135,1.15 [0.81-1.62],0.4326491749371352
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9394,40,0.74 [0.40-1.36],0.3341861150890728
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9940,586,0.90 [0.76-1.06],0.201075683981018
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19298,6382,1.13 [1.08-1.19],1.6592292863304325e-06
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23160,99,1.21 [0.83-1.76],0.3286437622958131
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8273,118,0.82 [0.58-1.16],0.254953167013548
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19680,357,1.16 [0.94-1.44],0.1717514890988836
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10011,1856,1.11 [1.01-1.21],0.0233324553086617
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12064,161,0.80 [0.59-1.09],0.1631182249735364
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8283,128,0.94 [0.67-1.33],0.7369733286588356
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19309,89,0.90 [0.60-1.37],0.6367716327329722
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10399,1045,0.88 [0.77-0.99],0.0326436142515349
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8217,62,2.28 [1.51-3.44],8.477737765347981e-05
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9394,40,1.10 [0.60-2.04],0.7536227339714026
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23419,90,1.08 [0.72-1.63],0.7159012121292796
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23420,84,1.10 [0.72-1.67],0.6735820779823567
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22214,2994,0.99 [0.92-1.06],0.7153861849403684
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20177,957,1.02 [0.90-1.16],0.7213377411464281
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11917,50,0.98 [0.56-1.71],0.9447704133926592
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23345,639,1.61 [1.39-1.87],4.2438738804538785e-10
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8310,155,1.39 [1.03-1.88],0.0305519757356289
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8317,162,0.92 [0.68-1.24],0.5723659570122315
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8309,154,1.37 [1.01-1.85],0.0434890029933329
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23391,89,1.27 [0.84-1.93],0.2576245055775787
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21598,2378,1.01 [0.94-1.10],0.7362565178499478
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11985,82,0.80 [0.52-1.24],0.3264666625839925
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9423,69,0.70 [0.44-1.11],0.1309743003307807
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9499,145,0.85 [0.61-1.17],0.3167959512530541
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9407,53,0.74 [0.43-1.26],0.2631513309023237
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9454,100,0.65 [0.44-0.95],0.0260825400732165
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19743,420,1.26 [1.03-1.53],0.0256064508531076
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22910,204,1.57 [1.20-2.05],0.0009282306449155
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9479,125,0.90 [0.63-1.28],0.5599816256650002
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9378,24,0.92 [0.41-2.06],0.830392249779898
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9570,216,0.94 [0.72-1.23],0.6618683117091957
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9447,93,0.76 [0.50-1.14],0.1805108091042444
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9562,208,0.89 [0.68-1.17],0.4235042157859999
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23109,48,2.32 [1.40-3.86],0.0011352924256927
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8311,156,1.04 [0.77-1.41],0.7782319602564466
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23138,3815,1.52 [1.42-1.62],2.7252147308096962e-37
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19417,94,1.52 [0.99-2.34],0.0538176766068046
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19792,185,1.93 [1.45-2.56],4.914472870229437e-06
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22823,40,0.77 [0.43-1.39],0.3942188536669061
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19491,271,0.93 [0.74-1.18],0.5707759736661586
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23186,403,0.92 [0.76-1.11],0.3911827874844303
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9391,37,0.91 [0.48-1.70],0.7655122807053892
